{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:48:42Z","timestamp":1770688122592,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,15]]},"DOI":"10.7759\/cureus.50596","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T19:13:35Z","timestamp":1702667615000},"source":"Crossref","is-referenced-by-count":1,"title":["Spectacular Improvement of Paradoxical Reaction in Tuberculosis after Tumor Necrosis Factor-Alpha Antagonist Therapy"],"prefix":"10.7759","author":[{"given":"Myriam","family":"Samad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles Antoine","family":"Dallevet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yacine","family":"Tandjaoui-Lambiotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Bourgarit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Jaquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(08)70184-1","article-title":"Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings","volume":"8","author":"Meintjes G","year":"2008","unstructured":"Meintjes G, Lawn SD, Scano F, et al.. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008, 8:516-23. 10.1016\/S1473-3099(08)70184-1","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00091010","article-title":"Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome","volume":"37","author":"Tadokera R","year":"2011","unstructured":"Tadokera R, Meintjes G, Skolimowska KH, et al.. Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J. 2011, 37:1248-59. 10.1183\/09031936.00091010","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2009.05.006","article-title":"Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis","volume":"59","author":"Cho OH","year":"2009","unstructured":"Cho OH, Park KH, Kim T, et al.. Paradoxical responses in non-HIV-infected patients with peripheral lymph node tuberculosis. J Infect. 2009, 59:56-61. 10.1016\/j.jinf.2009.05.006","journal-title":"J Infect"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-012-0376-9","article-title":"Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients","volume":"41","author":"Geri G","year":"2013","unstructured":"Geri G, Passeron A, Heym B, Arlet JB, Pouchot J, Capron L, Ranque B. Paradoxical reactions during treatment of tuberculosis with extrapulmonary manifestations in HIV-negative patients. Infection. 2013, 41:537-43. 10.1007\/s15010-012-0376-9","journal-title":"Infection"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-002-0821-2","article-title":"Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients","volume":"21","author":"Cheng VC","year":"2002","unstructured":"Cheng VC, Ho PL, Lee RA, et al.. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis. 2002, 21:803-9. 10.1007\/s10096-002-0821-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(77)90041-1","article-title":"Lymph node tuberculosis: a comparison of various methods of treatment","volume":"58","author":"Campbell IA","year":"1977","unstructured":"Campbell IA, Dyson AJ. Lymph node tuberculosis: a comparison of various methods of treatment. Tubercle. 1977, 58:171-9. 10.1016\/0041-3879(77)90041-1","journal-title":"Tubercle"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040573","article-title":"Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults","volume":"351","author":"Thwaites GE","year":"2004","unstructured":"Thwaites GE, Nguyen DB, Nguyen HD, et al.. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004, 351:1741-51. 10.1056\/NEJMoa040573","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(87)91127-5","article-title":"Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei","volume":"2","author":"Strang JI","year":"1987","unstructured":"Strang JI, Kakaza HH, Gibson DG, Girling DJ, Nunn AJ, Fox W. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet. 1987, 2:1418-22. 10.1016\/s0140-6736(87)91127-5","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1900116","article-title":"Prednisone for prevention of paradoxical tuberculosis-associated IRIS. Reply","volume":"380","author":"Meintjes G","year":"2019","unstructured":"Meintjes G, Stek C, Maartens G. Prednisone for prevention of paradoxical tuberculosis-associated IRIS. Reply. N Engl J Med. 2019, 380:1781. 10.1056\/NEJMc1900116","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-012-0129-5","article-title":"Management of the immune reconstitution inflammatory syndrome","volume":"9","author":"Meintjes G","year":"2012","unstructured":"Meintjes G, Scriven J, Marais S. Management of the immune reconstitution inflammatory syndrome. Curr HIV\/AIDS Rep. 2012, 9:238-50. 10.1007\/s11904-012-0129-5","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-4-9","article-title":"Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options","volume":"4","author":"Murdoch DM","year":"2007","unstructured":"Murdoch DM, Venter WD, Van Rie A, Feldman C. Immune reconstitution inflammatory syndrome (IRIS): review of common infectious manifestations and treatment options. AIDS Res Ther. 2007, 4:9. 10.1186\/1742-6405-4-9","journal-title":"AIDS Res Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0693","article-title":"Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients","volume":"16","author":"Breton G","year":"2012","unstructured":"Breton G, Bourgarit A, Pavy S, et al.. Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients. Int J Tuberc Lung Dis. 2012, 16:1365-70. 10.5588\/ijtld.11.0693","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-023-04564-2","article-title":"The use of TNF-\u03b1 antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review","volume":"42","author":"Armange L","year":"2023","unstructured":"Armange L, Lacroix A, Petitgas P, et al.. The use of TNF-\u03b1 antagonists in tuberculosis to control severe paradoxical reaction or immune reconstitution inflammatory syndrome: a case series and literature review. Eur J Clin Microbiol Infect Dis. 2023, 42:413-22. 10.1007\/s10096-023-04564-2","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1995.83.2.0359","article-title":"Paradoxical progression of tuberculous lesions during chemotherapy of central nervous system tuberculosis. Report of four cases","volume":"83","author":"Rao GP","year":"1995","unstructured":"Rao GP, Nadh BR, Hemaratnan A, Srinivas TV, Reddy PK. Paradoxical progression of tuberculous lesions during chemotherapy of central nervous system tuberculosis. Report of four cases. J Neurosurg. 1995, 83:359-62. 10.3171\/jns.1995.83.2.0359","journal-title":"J Neurosurg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/BF01844751","article-title":"Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy: literature review and a case report","volume":"139","author":"Hejazi N","year":"1997","unstructured":"Hejazi N, Hassler W. Multiple intracranial tuberculomas with atypical response to tuberculostatic chemotherapy: literature review and a case report. Acta Neurochir (Wien). 1997, 139:194-202. 10.1007\/BF01844751","journal-title":"Acta Neurochir (Wien)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/173413-spectacular-improvement-of-paradoxical-reaction-in-tuberculosis-after-tumor-necrosis-factor-alpha-antagonist-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:38Z","timestamp":1707509378000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/173413-spectacular-improvement-of-paradoxical-reaction-in-tuberculosis-after-tumor-necrosis-factor-alpha-antagonist-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.50596","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}